• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ITPKC作为三阴性乳腺癌新辅助化疗的预后和预测生物标志物

ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.

作者信息

Oshi Masanori, Newman Stephanie, Murthy Vijayashree, Tokumaru Yoshihisa, Yan Li, Matsuyama Ryusei, Endo Itaru, Takabe Kazuaki

机构信息

Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, NY 14263, USA.

Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

出版信息

Cancers (Basel). 2020 Sep 25;12(10):2758. doi: 10.3390/cancers12102758.

DOI:10.3390/cancers12102758
PMID:32992708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7601042/
Abstract

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with higher mortality than the others. Pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is considered as a surrogate to predict survival. Inositol 1,4,5-trisphosphate 3-kinase C () is a negative regulator of T cell activation, and reduction in function is known to promote Kawasaki disease. Given the role of tumor infiltrating lymphocytes in NAC and since TNBC has the most abundant immune cell infiltration in breast cancer, we hypothesized that the expression level is associated with NAC response and prognosis in TNBC. The gene was expressed in the mammary gland, but its expression was highest in breast cancer cells among other stromal cells in a bulk tumor. expression was highest in TNBC, associated with its survival, and was its independent prognostic factor. Although high was not associated with immune function nor with any immune cell fraction, low significantly enriched cell proliferation-related gene sets in TNBC. TNBC with low achieved a significantly higher pCR rate after NAC. To the best of our knowledge, this is the first report to demonstrate that gene expression may be useful as a prognostic and predictive biomarker in TNBC.

摘要

三阴性乳腺癌(TNBC)是乳腺癌中最具侵袭性的亚型,其死亡率高于其他亚型。新辅助化疗(NAC)后的病理完全缓解(pCR)被视为预测生存的替代指标。肌醇1,4,5-三磷酸3-激酶C()是T细胞活化的负调节因子,已知功能降低会促进川崎病。鉴于肿瘤浸润淋巴细胞在NAC中的作用,且由于TNBC在乳腺癌中具有最丰富的免疫细胞浸润,我们推测表达水平与TNBC的NAC反应和预后相关。基因在乳腺中表达,但其在整块肿瘤的其他基质细胞中,在乳腺癌细胞中的表达最高。表达在TNBC中最高,与其生存相关,是其独立的预后因素。虽然高表达与免疫功能及任何免疫细胞亚群均无关,但低表达在TNBC中显著富集细胞增殖相关基因集。NAC后,低表达的TNBC达到显著更高的pCR率。据我们所知,这是第一份证明基因表达可能作为TNBC的预后和预测生物标志物的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/7166d34dd043/cancers-12-02758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/92de0dfd08df/cancers-12-02758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/699a13e106f9/cancers-12-02758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/45702109f7be/cancers-12-02758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/549b96a48a88/cancers-12-02758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/7166d34dd043/cancers-12-02758-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/92de0dfd08df/cancers-12-02758-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/699a13e106f9/cancers-12-02758-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/45702109f7be/cancers-12-02758-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/549b96a48a88/cancers-12-02758-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b098/7601042/7166d34dd043/cancers-12-02758-g005.jpg

相似文献

1
ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.ITPKC作为三阴性乳腺癌新辅助化疗的预后和预测生物标志物
Cancers (Basel). 2020 Sep 25;12(10):2758. doi: 10.3390/cancers12102758.
2
Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.全身免疫炎症指数与三阴性乳腺癌新辅助化疗疗效及预后的关系。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(9):958-965. doi: 10.11817/j.issn.1672-7347.2021.200951.
3
Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy.血小板反应蛋白2是新辅助化疗的三阴性乳腺癌患者的功能预测和预后生物标志物。
Pathol Oncol Res. 2022 Aug 30;28:1610559. doi: 10.3389/pore.2022.1610559. eCollection 2022.
4
A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.一种新型三基因评分作为三阴性乳腺癌新辅助化疗后病理完全缓解的预测生物标志物
Cancers (Basel). 2021 May 16;13(10):2401. doi: 10.3390/cancers13102401.
5
Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.肿瘤浸润淋巴细胞及拓扑异构酶IIα表达在紫杉烷-蒽环类新辅助化疗后三阴性乳腺癌患者临床结局预测中的意义
Chemotherapy. 2017;62(4):246-255. doi: 10.1159/000470900. Epub 2017 May 5.
6
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes.基于NanoString技术的免疫相关基因特征在三阴性乳腺癌新辅助治疗中的预后和预测价值:与肿瘤浸润淋巴细胞的关系
Breast Cancer Res Treat. 2015 Jun;151(3):619-27. doi: 10.1007/s10549-015-3438-8. Epub 2015 May 26.
7
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.三阴性乳腺癌新辅助化疗后残留肿瘤中肿瘤浸润性CD8 +和FOXP3 +淋巴细胞的预后意义及这些参数的变化:一项回顾性多中心研究
Breast Cancer Res. 2015 Sep 4;17(1):124. doi: 10.1186/s13058-015-0632-x.
8
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.浸润淋巴细胞与不同亚型乳腺癌患者预后的关系:新辅助化疗治疗 3771 例患者的汇总分析
Lancet Oncol. 2018 Jan;19(1):40-50. doi: 10.1016/S1470-2045(17)30904-X. Epub 2017 Dec 7.
9
Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy.新辅助化疗治疗三阴性乳腺癌中肿瘤浸润淋巴细胞的预测和预后影响
Ecancermedicalscience. 2017 Aug 15;11:759. doi: 10.3332/ecancer.2017.759. eCollection 2017.
10
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors.多组学数据的整合表明三阴性化疗耐药性乳腺癌中错配修复和微管通路下调。
Breast Cancer Res. 2023 May 24;25(1):57. doi: 10.1186/s13058-023-01656-x.

引用本文的文献

1
Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer Using Pre-Treatment Histopathologic Images.利用治疗前组织病理学图像预测三阴性乳腺癌的新辅助化疗反应
Cancers (Basel). 2025 Jul 22;17(15):2423. doi: 10.3390/cancers17152423.
2
Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer Using Pre-Treatment Histopathologic Images.利用治疗前组织病理学图像预测三阴性乳腺癌的新辅助化疗反应
ArXiv. 2025 Jul 26:arXiv:2505.14730v2.
3
Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment.

本文引用的文献

1
MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway.MEX3A 通过 PI3K/AKT 信号通路促进三阴性乳腺癌的增殖和迁移。
Exp Cell Res. 2020 Oct 15;395(2):112191. doi: 10.1016/j.yexcr.2020.112191. Epub 2020 Jul 29.
2
Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.淋巴管侵犯的转录组特征,胰腺导管腺癌转移的已知危险因素
Cancers (Basel). 2020 Jul 24;12(8):2033. doi: 10.3390/cancers12082033.
3
The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer.
间皮素(MSLN)在三阴性乳腺癌中高表达,并与细胞增殖增强和促炎性肿瘤微环境相关。
Ann Surg Oncol. 2025 Jun;32(6):4476-4486. doi: 10.1245/s10434-025-17117-y. Epub 2025 Mar 13.
4
Clinico-pathological factors predicting pathological response in early triple-negative breast cancer.预测早期三阴性乳腺癌病理反应的临床病理因素
NPJ Breast Cancer. 2025 Feb 13;11(1):15. doi: 10.1038/s41523-025-00729-8.
5
Role of Epigenetic Factors in Determining the Biological Behavior and Prognosis of Hepatocellular Carcinoma.表观遗传因素在决定肝细胞癌生物学行为和预后中的作用
Diagnostics (Basel). 2024 Aug 31;14(17):1925. doi: 10.3390/diagnostics14171925.
6
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.CD133 表达与 DNA 修复能力降低、对 ER 阳性/HER2 阴性乳腺癌化疗反应更好和生存时间延长相关。
Breast Cancer Res Treat. 2024 Nov;208(2):415-427. doi: 10.1007/s10549-024-07434-3. Epub 2024 Jul 17.
7
Global biomarker trends in triple-negative breast cancer research: a bibliometric analysis.三阴性乳腺癌研究中的全球生物标志物趋势:一项文献计量分析
Int J Surg. 2024 Dec 1;110(12):7962-7983. doi: 10.1097/JS9.0000000000001799.
8
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.CD133表达与雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌中较少的DNA修复、更好的化疗反应及生存相关。
Res Sq. 2024 Mar 27:rs.3.rs-4148608. doi: 10.21203/rs.3.rs-4148608/v1.
9
Biomarker Research in World Journal of Oncology.《世界肿瘤学杂志》中的生物标志物研究。
World J Oncol. 2023 Feb;14(1):1-3. doi: 10.14740/wjon1577. Epub 2023 Feb 26.
10
Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review.三阴性乳腺癌与新辅助化疗反应的预测标志物:一项系统综述。
Int J Mol Sci. 2023 Feb 3;24(3):2969. doi: 10.3390/ijms24032969.
E2F 通路评分作为 ER+/HER2- 乳腺癌新辅助治疗反应的预测性生物标志物。
Cells. 2020 Jul 8;9(7):1643. doi: 10.3390/cells9071643.
4
Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer.免疫细胞对乳腺癌中糖皮质激素受体表达的贡献。
Int J Mol Sci. 2020 Jun 30;21(13):4635. doi: 10.3390/ijms21134635.
5
Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma.成纤维细胞作为胰腺导管腺癌根治性切除的生物学标志物。
Int J Mol Sci. 2020 May 29;21(11):3890. doi: 10.3390/ijms21113890.
6
Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.诺丁汉组织学分级 3 级乳腺癌的分子生物学特征。
Ann Surg Oncol. 2020 Oct;27(11):4475-4485. doi: 10.1245/s10434-020-08608-1. Epub 2020 May 20.
7
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma.免疫细胞溶解活性助力全面了解肝细胞癌的免疫格局
Cancers (Basel). 2020 May 13;12(5):1221. doi: 10.3390/cancers12051221.
8
A Novel 4-Gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer.一种预测乳腺癌生存、远处转移及新辅助治疗反应的新型四基因评分
Cancers (Basel). 2020 May 2;12(5):1148. doi: 10.3390/cancers12051148.
9
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.高表达 microRNA-143 与雌激素受体阳性乳腺癌中有利的肿瘤免疫微环境和更好的生存相关。
Int J Mol Sci. 2020 May 1;21(9):3213. doi: 10.3390/ijms21093213.
10
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.miR-34a 高表达与乳腺癌侵袭性生物学行为弱相关,但与生存无关。
Int J Mol Sci. 2020 Apr 26;21(9):3045. doi: 10.3390/ijms21093045.